Objectives: This study sought to investigate the 3-year follow-up results of OLIVE registry patients.
Even though endovascular aortic aneurysm repair (EVAR) has been embraced and widely adopted for being minimally invasive compared to open surgery, it has a number of shortcomings, as does open surgery. Both of these imperfect solutions may be appropriate to treat select abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs).
HOW DID YOU BEGIN USING ENDOANCHORS? I began using the EndoAnchor as part of the ANCHOR registry in early 2012. I then realized early on that EndoAnchors had the ability to secure the endograft in a similar fashion to a standard open surgical repair. I felt that this could be beneficial in those with normal anatomy, and younger presentation, as well as older patients with severely angulated and short necks.
Endovascular aneurysm repair (EVAR) has evolved significantly since 1991 when Dr. Juan Parodi detailed in his pioneering report the treatment of five abdominal aortic aneurysm (AAA) patients with knitted Dacron tube endografts.1 High failure rates of the first generation of endografts were due largely to stent migration and associated seal failure. Modern endografts are more advanced structurally to achieve greater fixation and sealing than their progenitor devices.
New techniques for superficial venous disease offer advantages, but reimbursement issues raise challenges for adoption.
Key elements in recanalization and stenting in the chronically occluded IVC and iliac vein systems.
Iliac vein stenting is an extension of arterial stent technology. The two share some technical similarities and much of the hardware; however, the indications for and purpose of iliac vein stenting are fundamentally different from arterial practice. Pathophysiologic differences require specific modifications of techniques as well. The clinical outcome of iliac vein stenting has been surprising in some aspects, challenging long-held core concepts.
Experts share their advice on the best approach to forming a “PERT” and discuss the benefits that they can offer.
Acute arterial thromboembolism and venous thrombosis are limb-threatening and potentially life-threatening conditions. Acute arterial thrombus prohibits perfusion to affected limbs, resulting in emergent limb salvage situations.
Pseudoaneurysms are distinguished from true aneurysms in that they do not include all three layers of the arterial wall. They typically develop as a result of inflammation, infection, and traumatic or iatrogenic injury.1 In contrast, although visceral artery aneurysms (VAAs) are rare, their diagnosis has increased with broader application of cross-sectional imaging and the development of improved CT angiography (CTA).2
Pelvic venous congestion syndrome is most commonly recognized as the persistence of noncyclical chronic pelvic pain for longer than 6 months in the absence of known pelvic pathology. In the presence of pelvic varices, it is associated with a myriad of nonspecific symptoms, such as bloating, backache, dysmenorrhea, dyspareunia, bladder instability, and an irritable bowel; these are not infrequently associated with lower limb varicosities and hemorrhoids.1
Embolization techniques and technology are evolving every year. We have come a long way from flow-directed polyvinyl alcohol and pushable coils to reabsorbable materials and detachable technology with extremely high accuracy. I have been using detachable coils in addition to pushable technology in my practice for a number of years. The original reason for choosing detachable coils was their precision, which results in increased patient safety.
Despite widespread treatment of AV access stenosis with PTA, we have a limited understanding of what we are treating, why it responds to dilation, and if lesion characteristics can be used to guide treatment.
An interview with Scott O. Trerotola, MD, regarding the study of DCBs in arteriovenous fistulas.
An innovative device that aims to provide the benefits of kidney transplantation while addressing the limited number of donor organs.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos